Subtyping and antifungal susceptibilities of Candida spp. in the intensive care unit of a Greek general hospital

被引:12
作者
Kanellopoulou, M
Stamos, G
Petinnelli, I
Savala, M
Tzimogianni, A
Legakis, NJ
Foustoukou, M
Papafragas, E
Velegraki, A
机构
[1] Univ Athens, Sch Med, Dept Microbiol, Mycol Reference Lab, GR-11527 Athens, Greece
[2] Dist Gen Hosp Nikea, Dept Microbiol, Piraeus, Greece
关键词
Candida spp; ICU; antifungal susceptibility; subtyping; PFGE;
D O I
10.1016/S0924-8579(01)00367-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study identified the Candida spp., susceptibility to antifungal agents and the prevailing Candida albicans subtypes responsible for infections or colonization of 42 patients in the ICU over a 6-month period. Most isolates were C. albicans (66.1%) and Candida tropicalis (28.3%) all of which were susceptible in vitro to antifungal agents. Subtypes of the C. albicans isolates were identified by pulsed field gel electrophoresis Sfi I chromosomal digests. Two major C. albicans subtypes were identified, whereas subtype heterogeneity was found among strains of Candida glabrata and C. tropicalis. Sfi I PFGE restriction patterns were able to discriminate between sub-populations of C. albicans isolates, clustering them into distinct, epidemiologically congruous groups. (C) 2001 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 30 条
[1]   Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates [J].
Barchiesi, F ;
Di Francesco, LF ;
Arzeni, D ;
Caselli, F ;
Gallo, D ;
Scalise, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (03) :184-187
[2]   STABILITY OF KARYOTYPE IN SERIAL ISOLATES OF CANDIDA-ALBICANS FROM NEUTROPENIC PATIENTS [J].
BARTON, RC ;
VANBELKUM, A ;
SCHERER, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (04) :794-796
[3]  
COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407
[4]   DISSEMINATED CANDIDIASIS DUE TO AMPHOTERICIN B-RESISTANT CANDIDA-ALBICANS [J].
CONLY, J ;
RENNIE, R ;
JOHNSON, J ;
FARAH, S ;
HELLMAN, L .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :761-764
[5]   Multilocus genotypes and DNA fingerprints do not predict variation in azole resistance among clinical isolates of Candida albicans [J].
Cowen, LE ;
Sirjusingh, C ;
Summerbell, RC ;
Walmsley, S ;
Richardson, S ;
Kohn, LM ;
Anderson, JB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :2930-2938
[6]  
DELABESSE B, 1993, J CLIN MICROBIOL, V31, P2933
[7]  
DiazGuerra TM, 1997, J CLIN MICROBIOL, V35, P856
[8]   Geotrichum capitatum infection in a neutropenic patient. Case report and literature review. [J].
Fouassier, M ;
Joly, D ;
Cambon, M ;
Peigue-Lafeuille, H ;
Condat, P .
REVUE DE MEDECINE INTERNE, 1998, 19 (06) :431-433
[9]   Fluconazole versus Candida albicans:: A complex relationship [J].
Graybill, JR ;
Montalbo, E ;
Kirkpatrick, WR ;
Luther, MF ;
Revankar, SG ;
Patterson, TF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) :2938-2942
[10]   Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans [J].
Hoppe J.E. ;
Frey P. .
European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 (3) :188-191